Avantor Investor Conference Presentation Deck
Reconciliations of GAAP to non-GAAP measures (continued)
(Shares in M)
Diluted (loss) earnings per share (GAAP)
Dilutive impact of convertible instruments
Normalization for shares issued in IPO
Fully diluted earnings per share (non-GAAP)
Amortization
Loss on extinguishment of debt
Net foreign currency loss (gain) from financing activities
Other stock-based compensation expense (benefit)
Acquisition-related expenses
Integration-related expenses and other
Purchase accounting adjustments
Restructuring and severance charges
Receipt of disgorgement penalty
Income tax (benefit) applicable to pretax adjustments
Adjusted EPS (non-GAAP)
Diluted weighted average share count (GAAP)
Share count for Adjusted EPS (non-GAAP)
Navantor™
Full Year
2019
$(0.84)
0.19
0.71
0.06
0.49
0.11
0.06
0.04
(0.02)
0.04
(0.20)
$0.58
401
643
Full Year
2020
$0.09
0.09
0.18
0.48
0.54
0.03
0.01
(0.35)
$0.89
583
643
Full Year
2021
$0.85
0.04
0.89
0.45
0.03
0.12
0.03
0.01
(0.02)
(0.10)
$1.41
600
643
9 months ended
9/30/2022
$0.80
0.80
0.35
0.01
0.02
0.01
0.01
(0.11)
$1.09
680
680
41st Annual J.P. Morgan Healthcare Conference
20View entire presentation